Prevalence of hepatitis C virus antibodies among blood donors in Northern Jordan

Jordan Medical Journal

Volumn 42, Issue 3, 2008, Pages 179-183

  Rashdan, Abdullah ^a,b   Hijjawi, Shadi ^a   Jadallah, Khaled ^a   Matalka, Ismail ^a  

^a KING ABDULLAH UNIVERSITY HOSPITAL   (Jordan)

^b NONE   (Jordan)

Author keywords

Blood donors; HCV antibody; HCV genotype; Hepatitis C virus

Indexed keywords

GENOMIC RNA; HEPATITIS C ANTIBODY;

ANTIBODY SCREENING; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS C VIRUS; HUMAN; JORDAN; MALE; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; SERODIAGNOSIS;

EID: 58149112238     PISSN: 04469283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Choo Q, Kuo G, Overby L .R, Bradley D. W, et al. Isolation of a cDNA clone derived from a bloodborne non-A non-B viral hepatitis genome. Science 1989; 244:358-362.
2. Sharara AI, Hunt CM, Hamilton JD. Hepatitis C. Ann Int Med 1996; 125:658-668.
3. Chen DS. Public health measures to control hepatitis B virus infection in the developing countries of the Asia-Pacific region. J Gastroenterol Hepatol 2000; 15(suppl.):E7-10.
4. Khattak MF et al. Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. Journal of the Pakistan Medical Association 2002; 59:398-402.
5. World Health Organization. Hepatitis C: global prevalence. Wkly Epidemiol Rec. 1997; 72:341-344.
6. World Health Organization. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hep. 1999; 6:35-47.
7. Alter MJ, Margolis H, Krawczynski et al. The natural history of community- acquired hepatitis C in the United States. N Engl J Med 1992; 327: 1899-1905.
8. Candotti D, Temple J, Sarkodie F, Allain JP. Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana. West Afr J Virol 2003; 77: 7914-7923.
9. Hassan F, Jeffers LJ, Demedina M et al. Hepatitis C-associated hepatocellular carcinoma. Hepatology 1990; 12: 589-591.
10. Hassan MM, Zaghloul AS, El-Serag HB et al. The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients. J Clin Gastroenterol 2001; 33: 123-126.
11. Montalto G, Cervello M, Giannitrapani L, Dantona F, Terranova A, Castagnetta LA. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann N Y Acad Sci 2002; 963: 13-20.
12. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000; 20: 1-16.
13. Madhava V, Burgess C, Drucker E. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis 2002; 2: 293-302.
14. Dodd RY. Transfusion-transmitted hepatitis virus infection. Hematol Oncol Cl in North Am 1995; 9: 137-154.
15. Watanabe J, Matsumoto C, Fujimura K, Shimade T , Yoshizawa H, Okamoto H, et al. Predictive value of screening tests for persistent hepatitis virus infection evidenced by viraemia. Japanese experience. Vox Sang 1993; 65: 199-203.
16. Bresters D, Cuypers HTM, Reesink HW, Schaasberg WP, Vander Poel CL, Mauser-Bunschoten EP, et al. Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus. Vox Sang 1992; 62: 213-217.
17. Jbara I, Abu Alshiekh NK et al. Prevalence of hepatitis C virus antibodies among blood donors at Prince Hashem Hospital, Zarka- Jordan. J Med J 2006; 40 (3): 190-193.
18. Farouk A Alquadan. Prevalence of hepatitis B surface antigen and anti hepatitis C virus among blood donors in Jordan. Al- Manareh 2003; 9: 147-155.
19. Saved RM, Khaled A, et al. Prevalence of hepatitis B and C among blood donors; Saudi Medical Journal 2000; 21: 942-944.
20. Conry-Cantilena C, VanRaden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med. 1996; 334:1691-1696.
21. Delage G, Infante-Rivard C, Chiavetta J-A, Willems B, Pi D, Fast M. Risk factors for acquisition of hepatitis C virus infection in blood donors: Results of a case-control study. Gastroenterology 1999; 116:893-899.
22. Choo QL, Weiner AJ, Overby LR,Kuo G, Houghton M, Bradley DW. Hepatitis C virus: the major causative agent of viral nonA, non-B hepatitis. Br Med Bull 1990; 46: 423-441.
23. Kuhnl P, Seidl S, Stange W, Beyer J, Sibrowski W, Flik J. Antibody to hepatitis C virus in German blood donors. Lancet 1989; 2: 324.
24. Janot C, Courouce AM, Maniez M. Antibodies to hepatitis C virus in French blood donors. Lancet 1989; 2: 796-797.
25. Sirchia G, Bellobuono A, Giovanetti A, Marconi M. Antibodies to hepatitis C virus in Italian blood donors. Lancet 1989; 2: 797.
26. Van der Poel CL. Hepatitis C virus: into the fourth generation. Vox Sang 1994; 67(Suppl 3): 95-98.
27. Cuthbert JA. Hepatitis C: progress and problems. Clin Microbiol Rev 1994; 7: 505-532.
28. Fathalla SE, Al-Jama AA, Badawy MS et al. Prevalence of hepatitis C virus infection in the Eastern Province of Saudi Arabia by re-DNA second generation and supplemental EIA tests. Saudi Med J 2003; 24 (Suppl 2): S120-121.
29. Halim NK, Ajayi OI. Risk factors and seroprevalence of hepatitis C antibody in blood donors in Nigeria. East Afr Med J 2000; 77: 410-412.
30. Ampofo W, Nii-Trebi N, Ansah J et al. Prevalence of blood-borne infectious diseases in blood donors in Ghana. J Clin Microbiol 2002; 40: 3523-3525.
31. Arthur RR, Hassan NF, Abdallah MY, el-Sharkawy MS, Saad MD, Hackbart BG, et al. Hepatitis C antibody prevalence in blood donors in different governorates in Egypt. Trans R Soc Trol Med Hyg 1997; 91: 271-274.